{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:19:38Z","timestamp":1787732378310,"version":"build-2784847793"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T00:00:00Z","timestamp":1521936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T00:00:00Z","timestamp":1521936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Region Zealand Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1111\/bjd.15769","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T15:52:42Z","timestamp":1498578762000},"page":"182-185","source":"Crossref","is-referenced-by-count":68,"title":["Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3734-9607","authenticated-orcid":false,"given":"L.","family":"Thorlacius","sequence":"first","affiliation":[{"name":"Department of Dermatology; Zealand University Hospital; Roskilde Denmark"},{"name":"Health Sciences Faculty; University of Copenhagen; Copenhagen Denmark"},{"name":"Musculoskeletal Statistics Unit; The Parker Institute, Bispebjerg and Frederiksberg Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-8779","authenticated-orcid":false,"given":"P.","family":"Theut Riis","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Zealand University Hospital; Roskilde Denmark"},{"name":"Health Sciences Faculty; University of Copenhagen; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.E.","family":"Jemec","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Zealand University Hospital; Roskilde Denmark"},{"name":"Health Sciences Faculty; University of Copenhagen; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,25]]},"reference":[{"key":"10.1111\/bjd.15769-BIB0001|bjd15769-cit-0001","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15769-BIB0002|bjd15769-cit-0002","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15769-BIB0003|bjd15769-cit-0003","first-page":"CD010081","article-title":"Interventions for hidradenitis suppurativa","volume":"10","author":"Ingram","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.15769-BIB0004|bjd15769-cit-0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15769-BIB0005|bjd15769-cit-0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"New Engl J Med"},{"issue":"Suppl. 2","key":"10.1111\/bjd.15769-BIB0006|bjd15769-cit-0006","doi-asserted-by":"crossref","first-page":"ii116","DOI":"10.1136\/annrheumdis-2012-202371","article-title":"Effect of IL-17A blockade with secukinumab in autoimmune diseases","volume":"72","author":"Patel","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.15769-BIB0007|bjd15769-cit-0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-016-0031-5","article-title":"Secukinumab: a new treatment option for psoriatic arthritis","volume":"3","author":"Mease","year":"2016","journal-title":"Rheumatol Ther"},{"key":"10.1111\/bjd.15769-BIB0008|bjd15769-cit-0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.15015","article-title":"Candida infections in psoriasis and psoriatic arthritis patients treated with interleukin-17 inhibitors and their practical management","volume":"177","author":"Saunte","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15769-BIB0009|bjd15769-cit-0009","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15769-BIB0010|bjd15769-cit-0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","volume":"148","author":"Dr\u00e9no","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15769-BIB0011|bjd15769-cit-0011","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.15769-BIB0012|bjd15769-cit-0012","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1111\/bjd.15769-BIB0013|bjd15769-cit-0013","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15769-BIB0014|bjd15769-cit-0014","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.15769-BIB0015|bjd15769-cit-0015","doi-asserted-by":"crossref","first-page":"e014733","DOI":"10.1136\/bmjopen-2016-014733","article-title":"Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes","volume":"7","author":"Thorlacius","year":"2017","journal-title":"BMJ Open"},{"key":"10.1111\/bjd.15769-BIB0016|bjd15769-cit-0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.15769-BIB0017|bjd15769-cit-0017","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15769-BIB0018|bjd15769-cit-0018","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.15769-BIB0019|bjd15769-cit-0019","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15769\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:28:25Z","timestamp":1676384905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/1\/182\/6732300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,25]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15769","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,25]]}}}